Management of Brain Metastases in Extensive Stage Small Cell Lung Cancer

This episode presents a clinical case illustrating how IMforte data inform maintenance decisions in extensive stage small cell lung cancer. A patient who has completed induction chemoimmunotherapy is evaluated with attention to performance status, disease burden, treatment response, and comorbid conditions. The discussion weighs expected progression free survival benefit against potential hematologic toxicity and treatment burden. Considerations related to shared decision making, goals of care, and long term planning are incorporated into the therapeutic framework. The case highlights how clinical trial evidence is translated into individualized treatment strategies in real world practice. Key decision points emphasize aligning maintenance therapy selection with both clinical characteristics and patient priorities.